Postdoc Soptlight: Easton Ford

Easton Ford is a postdoc in Melissa Smith's Laboratory in Biochemistry and Molecular Genetics. He has a PhD from the University of Louisville in Microbiology and Immunology.

Could you tell us about this work and how this achievement will impact your professional career?

"My appointment as a Visiting Postdoctoral Fellow at Yale School of Medicine marks a pivotal step toward my goal of becoming an independent investigator in immunology. In Kevin O'Connor's laboratory, I am combining cutting-edge antibody repertoire sequencing with functional immunology to investigate autoimmune diseases, with a particular focus on myasthenia gravis.

During my doctoral training, I applied long-read sequencing technologies to characterize immunoglobulin diversity at unprecedented resolution, uncovering extensive genetic variation absent from existing reference databases. At Yale, I am extending this work to directly link immunogenomic variation with antibody function and pathogenicity—bridging a critical gap between sequence and biology.

This opportunity carries particular weight given my background. I grew up in a small town with little exposure to scientific research as a viable career, and reaching this point reflects both personal perseverance and the steady investment of mentors who helped me navigate the path into academic science. I hope to pay that forward by encouraging others from similar backgrounds to pursue research.

Professionally, this fellowship is equipping me with the interdisciplinary training I need to lead innovative research at the intersection of genomics and immunology. It also strengthens my position to compete for independent funding and to contribute to the development of precision immunology approaches for diagnosing and treating immune-mediated diseases."

What is your research about?

"My research investigates how immunoglobulin genetic variation and B cell repertoire dynamics shape immune function in health and disease. Antibodies are central to protective immunity, yet the genetic and molecular factors that govern their diversity, specificity, and pathogenic potential remain incompletely understood.

To address this gap, I use long-read sequencing technologies to generate near full-length immunoglobulin heavy chain sequences. As lead developer of FLAIRR-seq (near Full-Length Adaptive Immune Receptor Repertoire sequencing), a near full-length antibody receptor repertoire sequencing method, I have helped establish an approach that simultaneously resolves variable (V), diversity (D), and joining (J) gene usage alongside constant region (IGHC) subclass assignment in a single read. Unlike traditional short-read methods, it captures the full architecture of antibody repertoires—allelic diversity, somatic hypermutation, and class-switch recombination—at unprecedented resolution.

Using these tools, I have uncovered substantial immunoglobulin constant region variation across individuals, much of which is missing from current germline databases. This has direct implications for interpreting immune responses, since subclass-specific differences influence antibody effector functions such as complement activation and Fc receptor binding.

At Yale, I am extending these genomic insights into functional immunology. In the O'Connor Lab, I study autoimmune diseases—particularly myasthenia gravis—by pairing antibody repertoire sequencing with antigen-specific functional assays. The goal is to identify features that distinguish pathogenic from protective antibody responses, including biased gene usage, somatic hypermutation patterns, and subclass distributions.

I also apply computational approaches to analyze repertoire diversity, clonal expansion, and gene usage across disease states. By comparing autoimmune cohorts to healthy controls, I aim to identify immunogenomic signatures associated with disease susceptibility and progression.

Ultimately, I am building a comprehensive framework that links antibody genetics, repertoire structure, and function. These insights stand to inform vaccine design, sharpen diagnostics, and guide the development of targeted immunotherapies."

What are your career goals and vision?

"My long-term goal is to lead an independent research program that integrates immunogenomics and functional immunology to better understand and treat immune-mediated diseases. I am particularly interested in how genetic variation within immunoglobulin loci shapes antibody responses—and how that variation contributes to disease susceptibility, progression, and therapeutic outcomes.

Building on my current work at UofL and Yale, I plan to develop a multi-omic framework that connects antibody sequence variation with functional activity: antigen specificity, effector function, and pathogenic potential. This will enable a more precise understanding of immune responses across diverse populations and disease contexts, moving the field beyond population-averaged models toward genuinely individualized immunology.

Beyond the science, I am committed to mentorship and to expanding access to research careers. Coming from a background with limited exposure to academic science, I know firsthand how much representation and guidance shape a career trajectory. I plan to mentor students from underrepresented and nontraditional backgrounds and to help build more inclusive pathways into biomedical research.

I also intend for my work to reach beyond the lab. By contributing to precision immunology approaches—improved diagnostics, more targeted therapies for autoimmune and infectious diseases—I hope to translate discoveries into meaningful clinical impact. Through innovative research, sustained mentorship, and broad collaboration, I aim to contribute meaningfully to both the scientific community and the next generation of researchers."

If you are a postdoc at UofL and want to share your accomplishments, email us at ulpda@louisville.edu.